Form 4: Guardant Health Director Converts RSUs to Common Stock

Guardant Health Director Steve Krognes converted 154 restricted stock units into common stock on September 30, 2025, increasing his direct common stock holdings.

Summary

• Steve E. Krognes, a Director of Guardant Health, Inc. (GH), acquired 154 shares of common stock.
• This acquisition occurred on September 30, 2025, through the conversion of Restricted Stock Units (RSUs).
• Following this transaction, Krognes directly beneficially owns 18,282 shares of Guardant Health common stock.
• He also directly beneficially owns 1,389 Restricted Stock Units.
• The RSUs were originally granted on August 9, 2022, with 25% vesting on June 30, 2023.
• The remaining 75% of the RSU award vests in substantially equal installments on each monthly anniversary of June 30, 2023, over a three-year period.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates a director increasing their direct ownership, albeit through a routine vesting event, which aligns management interests with shareholders. It is not a strong signal but generally viewed favorably.

Positives

• Director Steve E. Krognes increased his direct beneficial ownership of Guardant Health common stock by 154 shares, further aligning his interests with shareholders.
• The transaction represents a routine vesting of previously granted Restricted Stock Units, indicating the ongoing retention and compensation of key management.

Future Outlook

The remaining 1,389 Restricted Stock Units held by Director Steve E. Krognes are scheduled to vest in substantially equal monthly installments, continuing the process of converting RSUs into common stock over the three-year period from June 30, 2023.

Industry Context

This routine insider transaction reflects standard executive compensation practices within the biotechnology and healthcare diagnostics industry, where equity awards like Restricted Stock Units are common for aligning management incentives with long-term shareholder value.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholders through higher direct stock ownership.

Next Steps

• Continued vesting of the remaining 1,389 Restricted Stock Units held by Steve E. Krognes on a monthly basis, as per the original grant schedule.

Key Dates

Keywords

Guardant Health, GH, Steve Krognes, Director, Insider Transaction, Form 4, Restricted Stock Units, RSU conversion, Common Stock, Beneficial Ownership